List of works - Cecilie Johannessen Landmark

A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway

scientific article published on 06 July 2020

Antiepileptic Drug Interactions - Principles and Clinical Implications ⬇️

scientific article published on September 1, 2010

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis

scientific article published on 29 June 2015

Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications

scientific article published on 29 January 2013

Antiepileptic drug treatment of children at a referral centre for epilepsy--does admission make a difference?

scientific article

Antiepileptic drug withdrawal in juvenile myoclonic epilepsy

scientific article published on 15 November 2018

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

scientific article published on 13 August 2009

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

scientific article published on January 2008

Availability of antiepileptic drugs across Europe

scientific article

Challenges in epilepsy-The perspective of Norwegian epilepsy patients

scientific article published on 29 April 2019

Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications

scientific article published on 13 July 2016

Clarification about pregabalin and the Norwegian Prescription Database ⬇️

scientific article published on 01 May 2011

Clinical experience combined with therapeutic drug monitoring of lacosamide

scientific article published on 23 January 2020

Clinical use of antiepileptic drugs at a referral centre for epilepsy.

scientific article published on 8 April 2007

Continued importance of valproate for women with generalised epilepsy

scientific article published on 08 April 2019

Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs

scientific article

Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring

scientific article published on 12 December 2016

Drug interactions involving the new second- and third-generation antiepileptic drugs

scientific article published on January 2010

Electronic prescriptions and cooperation

scientific article published in January 2013

Epilepsy and cannabidiol: a guide to treatment

scientific article published on 01 February 2020

Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)

scientific article published on 10 June 2013

Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-A pharmacoepidemiological study and clinical implications.

scientific article

Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice

scientific article

Harmonised reference ranges for antiepileptic drugs

scientific article published on 26 June 2017

Host factors affecting antiepileptic drug delivery-pharmacokinetic variability

scientific article published on 21 October 2011

Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

scientific article published on 15 November 2019

Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy

scientific article published on 30 May 2019

Methodologies used to identify and characterize interactions among antiepileptic drugs

scientific article published on May 2012

Modifications of antiepileptic drugs for improved tolerability and efficacy

scientific article

Nonadherence to treatment regimens in epilepsy from the patient's perspective and predisposing factors: Differences between intentional and unintentional lack of adherence

scientific article published on 13 April 2019

Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway

scientific article published on 01 June 2019

Pharmacokinetic variability during long-term therapeutic drug monitoring of valproate, clobazam, and levetiracetam in patients with Dravet syndrome

scientific article published on 11 June 2020

Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication

scientific article published in August 2012

Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring

scientific article published on 11 February 2018

Pharmacokinetic variability of valproate in women of childbearing age.

scientific article

Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.

scientific article

Pharmacological management of epilepsy: recent advances and future prospects

scientific article

Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy

scientific article

Pharmacology and drug interactions of cannabinoids

scientific article published on 01 January 2020

Pharmacotherapy in epilepsy - does gender affect safety?

scientific article

Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population ⬇️

scientific article published on March 24, 2011

Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway

scientific article published on 20 July 2016

Proconvulsant effects of antidepressants - What is the current evidence?

scientific article published on 23 February 2016

Psychiatric comorbidity in patients with epilepsy: a population-based study ⬇️

scientific article published on July 29, 2010

Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines

scientific article published on 8 February 2018

Refractory epilepsy and nonadherence to drug treatment

scientific article published on 06 November 2019

Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy

scientific article published on 20 June 2020

Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation

scientific article published on 18 April 2019

Safety aspects of antiepileptic drugs—focus on pharmacovigilance ⬇️

scientific article published on November 8, 2011

Sexual function in people with epilepsy: Similarities and differences with the general population

scientific article published on 13 August 2019

Specific Patient Features Affect Antiepileptic Drug Therapy Decisions. Focus on Gender, Age, and Psychiatric Comorbidities

scientific article published on 25 September 2017

Targets for antiepileptic drugs in the synapse

scientific article published on 18 December 2006

The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.

scientific article published on August 2016

Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability

scientific article published on 7 January 2016

Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability

scientific article published on 27 March 2017

Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects

scientific article published on 13 February 2020

Therapeutic drug monitoring of gabapentin in various indications

scientific article published on 19 February 2019

Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy

scientific article published on 19 July 2019

Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.

scientific article published on 11 November 2017

Value of therapeutic drug monitoring in epilepsy

scientific article published on June 2008

Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy

scientific article published on 28 August 2013

[The prescription registry and abuse of pregabalin]

scientific article published on 01 February 2011

List of works by Cecilie Johannessen Landmark

A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway

Antiepileptic Drug Interactions - Principles and Clinical Implications ⬇️

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis

Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications

Antiepileptic drug treatment of children at a referral centre for epilepsy--does admission make a difference?

Antiepileptic drug withdrawal in juvenile myoclonic epilepsy

Antiepileptic drugs in epilepsy and other disorders--a population-based study of prescriptions

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

Availability of antiepileptic drugs across Europe

Challenges in epilepsy-The perspective of Norwegian epilepsy patients

Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications

Clarification about pregabalin and the Norwegian Prescription Database ⬇️

Clinical experience combined with therapeutic drug monitoring of lacosamide

Clinical use of antiepileptic drugs at a referral centre for epilepsy.

Continued importance of valproate for women with generalised epilepsy

Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs

Dosing strategies for antiepileptic drugs: from a standard dose for all to individualised treatment by implementation of therapeutic drug monitoring

Drug interactions involving the new second- and third-generation antiepileptic drugs

Electronic prescriptions and cooperation

Epilepsy and cannabidiol: a guide to treatment

Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2)

Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-A pharmacoepidemiological study and clinical implications.

Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice

Harmonised reference ranges for antiepileptic drugs

Host factors affecting antiepileptic drug delivery-pharmacokinetic variability

Interdisciplinary medication review to improve pharmacotherapy for patients with intellectual disabilities

Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy

Methodologies used to identify and characterize interactions among antiepileptic drugs

Modifications of antiepileptic drugs for improved tolerability and efficacy

Nonadherence to treatment regimens in epilepsy from the patient's perspective and predisposing factors: Differences between intentional and unintentional lack of adherence

Pharmacokinetic Variability and Clinical Use of Lacosamide in Children and Adolescents in Denmark and Norway

Pharmacokinetic variability during long-term therapeutic drug monitoring of valproate, clobazam, and levetiracetam in patients with Dravet syndrome

Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication

Pharmacokinetic variability of valproate during pregnancy - Implications for the use of therapeutic drug monitoring

Pharmacokinetic variability of valproate in women of childbearing age.

Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate-A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome.

Pharmacological management of epilepsy: recent advances and future prospects

Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy

Pharmacology and drug interactions of cannabinoids

Pharmacotherapy in epilepsy - does gender affect safety?

Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population ⬇️

Prevalence of Different Combinations of Antiepileptic Drugs and CNS Drugs in Elderly Home Care Service and Nursing Home Patients in Norway

Proconvulsant effects of antidepressants - What is the current evidence?

Psychiatric comorbidity in patients with epilepsy: a population-based study ⬇️

Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines

Refractory epilepsy and nonadherence to drug treatment

Relationship between saliva and plasma rufinamide concentrations in patients with epilepsy

Safety aspects of antiepileptic drugs-a population-based study of adverse effects relative to changes in utilisation

Safety aspects of antiepileptic drugs—focus on pharmacovigilance ⬇️

Sexual function in people with epilepsy: Similarities and differences with the general population

Specific Patient Features Affect Antiepileptic Drug Therapy Decisions. Focus on Gender, Age, and Psychiatric Comorbidities

Targets for antiepileptic drugs in the synapse

The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice.

Therapeutic Drug Monitoring of Clobazam and Its Metabolite-Impact of Age and Comedication on Pharmacokinetic Variability

Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability

Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects

Therapeutic drug monitoring of gabapentin in various indications

Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy

Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: A pharmacoepidemiological study of CNS-active drugs in Norway, 2004-2015.

Value of therapeutic drug monitoring in epilepsy

Withdrawal of antiepileptic drugs during presurgical video-EEG monitoring: an observational study for evaluation of current practice at a referral center for epilepsy

[The prescription registry and abuse of pregabalin]